Research Goals and Approaches Sample Clauses

Research Goals and Approaches. As the above literature review indicates, there is a need for a comprehensive analysis of the Assembly’s contribution in the field of international justice. This dissertation has three goals in view. Firstly, it seeks to identify the scope of the Assembly’s legal powers, according to the five functions above (i.e., quasi-legislative, quasi-judicial, empowering, recommendatory, sanctioning). This exercise aims to enrich the general understanding of the Assembly’s powers as a UN principal organ. A full explication of these institutional powers will also usefully serve to highlight the possibility for the Assembly to be used by States and other actors as part of a strategy to obtain accountability in an atrocity situation and, hopefully, to stimulate creative thinking on how the UN plenary body can be used to address impunity gaps. Secondly, the dissertation also seeks to provide a comprehensive survey of Assembly practice in the field of international justice, which includes the adoption of resolutions and decisions, as well as creation of subsidiary organs. By outlining this practice, the dissertation aims to highlight to the reader areas in which the Assembly has been active and to, conversely, identify areas where gaps or inconsistencies exist in responding to atrocity crimes. Thirdly, the dissertation aims to 77 Xxxxx Xxxxxxxx, ‘Uniting for Peace’ (1956) 50 AJIL 563, 564; Xxxx Xxxxxx, ‘Is the Xxxxxxx Plan Constitutional?’ (1950) 3(4) Western Political Q 512, 516; Xxxxxx Xxxxxxxx, ‘Expanding Role of the General Assembly: The Maintenance of International Peace and Security’ (1951) 29 Intl Conciliation 231; XX Xxxxxxx, ‘The “Uniting for Peace” Resolution of the United Nations’ (1951) 45(1) AJIL 129, 134. 78 Xxxxx Xxxxxxx ‘Uniting for Peace: Does it Still Serve any Useful Purpose?’ (2014) 108 AJIL Unbound 106; Xxxx Xxxxxx and Xxxxxxx Xxx, ‘The Uniting for Peace Resolution and Other Ways of Circumventing the Authority of the Security Council’ in Xxxxx Xxxxxx and Xxx Xxxx (eds), The UN Security Council and the Politics of International Authority (Routledge 2008); Xxxxx Xxxxxxx, ‘The Uniting for Peace Resolution on the Thirtieth Anniversary of its Passage’ (1981) 10 Colum J Transnatl L 1, 36-7; Xxxxx Xxxxxxxxxx, ‘Comment on Xxxxx Xxxxxxx, Uniting for Peace’ (2014) 108 AJIL Unbound 135; Xxxxxxx, ‘Age of International Justice’ (n 44).
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs

Related to Research Goals and Approaches

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Additional Information for Product Development Projects Outcome of product development efforts, such copyrights and license agreements. • Units sold or projected to be sold in California and outside of California. • Total annual sales or projected annual sales (in dollars) of products developed under the Agreement. • Investment dollars/follow-on private funding as a result of Energy Commission funding. • Patent numbers and applications, along with dates and brief descriptions.  Additional Information for Product Demonstrations: • Outcome of demonstrations and status of technology. • Number of similar installations. • Jobs created/retained as a result of the Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.